Michaela Liedtke MD

Michaela Liedtke, MD, is Associate Professor of Medicine at the Stanford University School of Medicine. She also holds several positions at Stanford Cancer Institute, including Medical Director of the Leukemia Inpatient Service, Co-Director of the Stanford Adolescent and Young Adult Cancer Program, and Co-Director of the Stanford Amyloid Center.

Dr. Liedtke received her medical degree from Hanover Medical School in Germany. She completed her residency in internal medicine at Albert Einstein College of Medicine and a fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center and Stanford University.

Dr. Liedtke specializes in research and treatment of multiple myeloma, amyloidosis, and acute lymphoblastic leukemia (ALL), with particular interest in myeloma CAR T-cell technology, amyloid fibril-targeting agents, and ALL in adolescents and young adults. She has contributed to numerous clinical and translational studies in her field.

Dr. Liedtke is a member of the American Society of Hematology and the American Society of Clinical Oncology. She also serves on the Leukemia Committee for the Southwest Oncology Group.

Dr. Liedtke is a member of the NCCN Acute Lymphoblastic Leukemia Panel and the NCCN Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström's Macroglobulinemia Panel.